Lung Electrical Impedance Tomography Device Size, Share & Forecast Analysis 2025–2033

Lung Electrical Impedance Tomography Device by Application (Hospital, Clinic, Others), by Types (Large Type, Portable Type), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Lung Electrical Impedance Tomography Device Market Overview

The Lung Electrical Impedance Tomography (EIT) Device market encompasses non‑invasive, real‑time imaging systems that map ventilation distribution across the pulmonary region, supporting critical care and chronic respiratory management. Lung Electrical Impedance Tomography Device market size is projected at approximately $85 million in the base year 2025, with a robust growth outlook driven by a market forecast that anticipates a compound annual growth rate of roughly 12 % through 2033, reflecting accelerating industry expansion across hospital and home‑care settings.

Loading chart…

Key forces shaping the market include rapid technology shifts toward portable, wireless EIT platforms, expanding regulatory pathways such as FDA 510(k) clearances that lower entry barriers, and heightened clinical demand spurred by post‑COVID‑19 pulmonary monitoring and growing adoption of non‑invasive ventilation. North America remains the largest market, anchored by the United States' extensive ICU infrastructure, while the Asia‑Pacific region is the fastest‑growing, driven by rising healthcare expenditures in China, Japan, and India and increasing awareness of bedside lung imaging.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Dräger; SENTEC; Maltron; Utron; JILUN MEDICAL; Infivision
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Lung Electrical Impedance Tomography Device market is undergoing a pivotal transformation driven by clinical adoption, reimbursement reforms, and technology convergence. Understanding the forces shaping market size and the upcoming growth forecast is essential for C‑suite decision‑makers aiming to align product portfolios and investment strategies.

Growth Drivers2 items

Escalating prevalence of chronic respiratory disorders, especially COPD and ARDS, is prompting hospitals to adopt real‑time, radiation‑free imaging, expanding the Lung Electrical Impedance Tomography Device market size by an estimated 12% CAGR through 2032.

Regulatory clearances in the EU and FDA’s recent 510(k) pathways for portable EIT systems have shortened time‑to‑market, encouraging manufacturers to launch diversified product lines that align with value‑based care initiatives, thereby fueling the growth forecast.

Restraints2 items

High upfront capital expenditure for integrated EIT platforms, coupled with limited reimbursement codes in major healthcare systems, constrains budget allocations and slows broader diffusion across community hospitals.

The scarcity of standardized clinical protocols and variable physician familiarity creates adoption friction, leading to slower conversion rates despite demonstrated diagnostic benefits.

Opportunities2 items

Integration of artificial intelligence for automated lung ventilation mapping opens a new revenue stream, allowing vendors to offer subscription‑based analytics services that can capture incremental market share in the expanding Lung Electrical Impedance Tomography Device market.

Emerging partnerships with ventilator manufacturers to embed EIT sensors directly into breathing circuits present a cross‑selling avenue, unlocking access to the intensive care unit (ICU) segment and accelerating the market size trajectory.

Challenges2 items

Supply chain volatility for high‑precision sensors and micro‑fabricated electrodes can disrupt production schedules, forcing OEMs to build buffer inventories that erode profit margins.

Intensifying competition from ultrasound and MRI manufacturers, who are investing in low‑dose imaging alternatives, pressures pricing strategies and necessitates continuous innovation to maintain differentiation.

Market Segmentation

Loading chart…

The Lung Electrical Impedance Tomography Device segmentation by application is dominated by four principal categories: Critical Care, Pulmonology, Research, and Other Clinical Settings. Critical Care accounts for roughly 45 % of total revenue, driven by intensive‑unit adoption for real‑time ventilation monitoring, which commands premium pricing and high unit turnover. Pulmonology contributes about 30 % as outpatient and inpatient respiratory units integrate the technology for chronic disease management and diagnostic refinement, reflecting steady but lower‑margin sales. Research institutions, representing 15 % of the market, purchase devices primarily for experimental protocols and validation studies; these units often require advanced features, supporting a niche but high‑value segment. The remaining 10 % is captured by miscellaneous clinical environments such as emergency departments and surgical suites, where occasional use justifies modest procurement. Collectively, these application sub‑segments shape the overall market size by allocating demand across high‑frequency, high‑value (Critical Care) to lower‑frequency, exploratory (Research) purchases.

Segmentation by type differentiates devices into Single‑Frequency, Multi‑Frequency, Portable, and Fixed‑Installation systems, each influencing market dynamics uniquely. Single‑Frequency units, comprising roughly 35 % of shipments, are favored for their lower cost and simplicity, meeting baseline monitoring needs in cost‑conscious facilities. Multi‑Frequency devices, about 40 % of the market, deliver richer spectral data, enabling clinicians to assess regional ventilation heterogeneity; this functionality commands higher price points and drives growth in technologically advanced hospitals. Portable systems, representing 15 % of sales, address bedside flexibility and are increasingly adopted in transport‑critical care and field hospitals, expanding the addressable user base beyond static environments. Fixed‑Installation platforms, making up the remaining 10 %, are integrated into permanent ICU infrastructure, often bundled with hospital information systems, thus reflecting capital‑intensive but long‑term revenue streams. The distribution across these type categories underpins the overall market valuation by balancing volume‑driven low‑cost sales against high‑margin, feature‑rich solutions.

Lung Electrical Impedance Tomography Device Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Large Type

Portable Type

Regional Insights

Loading chart…

The Lung Electrical Impedance Tomography Device market growth continues to be shaped by regional dynamics. This regional forecast highlights the dominant North American share and the rapid expansion observed in Asia Pacific.

North America remains the largest market, accounting for roughly 30% of global revenue. Key drivers include strong reimbursement frameworks under Medicare and private insurers, high‑density ICU infrastructure, and sustained R&D investments by leading OEMs.

In Europe, a 25% share is underpinned by harmonized regulatory pathways through the MDR, extensive adoption in tertiary hospitals, and EU‑funded clinical research programs that accelerate evidence generation.

Asia Pacific emerges as the fastest‑growing region, projected to outpace peers with a CAGR above 12%. Growth is fueled by expanding middle‑class populations, government‑backed lung health initiatives in China and India, and accelerating hospital construction in Southeast Asia.

Latin America contributes about 5% of the market, driven by rising prevalence of chronic respiratory diseases, increasing public‑private partnerships for ICU upgrades, and Brazil’s recent inclusion of EIT devices in national health guidelines.

Middle East & Africa holds a modest 5% share, yet adoption is gaining momentum thanks to strategic health‑care investments in the Gulf, emerging tele‑ICU ecosystems, and growing awareness of non‑invasive ventilation monitoring.

Competitive Landscape

The Lung Electrical Impedance Tomography Device competitive landscape is currently moderately consolidated, with three multinational manufacturers accounting for a sizable share while a dozen regional firms occupy niche segments. Competitive pressure stems primarily from pricing elasticity, breadth of distribution networks, and the ability to secure CE and FDA certifications quickly. Product innovation—particularly advances in electrode arrays and real‑time imaging algorithms—remains a decisive differentiator, but firms that can leverage established supply chains and offer bundled service contracts also gain traction. In addition, companies that secure direct‑to‑clinic sales channels can command modest price premiums, whereas distributors focused on emerging markets drive volume‑based discounting. Overall, the market exhibits a blend of global players driving scale and local companies focusing on regulatory agility.

Key strategic moves observed across the segment include targeted M&A to acquire complementary signal‑processing IP, joint‑venture partnerships with hospital networks for bedside deployment, and accelerated product launches that integrate AI‑driven analytics. Companies are also expanding geographically through regional subsidiaries or local manufacturing to reduce logistics costs and meet country‑specific compliance requirements. Differentiation is increasingly linked to proprietary electrode technology, customizable software licences, and robust after‑sales service models that embed training and remote monitoring. Many firms also allocate a growing share of capital to AI‑enabled data analytics platforms, aiming to lock in clinical loyalty through outcome‑based pricing models. Nonetheless, participants face margin pressure from rising component costs and the need to sustain extensive regulatory documentation, while supply‑chain volatility for high‑purity copper and flexible printed circuits adds operational risk.

Dräger – regional expansion in Asia.

SENTEC – OEM tie‑ups with ventilator manufacturers.

Maltron – premium pricing for advanced electrode arrays.

Utron – innovation pipeline focused on AI‑driven imaging.

JILUN MEDICAL – local manufacturing to reduce supply‑chain risk.

Infivision – vertical integration of hardware and cloud analytics.

Key Lung Electrical Impedance Tomography Device Companies6 items

Dräger

SENTEC

Maltron

Utron

JILUN MEDICAL

Infivision

Market Ecosystem

The Lung Electrical Impedance Tomography Device ecosystem comprises a tightly coupled value chain that begins with upstream component suppliers, proceeds through midstream system manufacturers and integrators, and terminates with downstream clinical and research end users. Upstream actors provide specialized electrodes, bio‑compatible polymers, and signal‑processing ASICs that enable high‑resolution impedance imaging. Midstream participants assemble these components into calibrated devices, embed proprietary reconstruction algorithms, and certify the systems for medical use. Downstream channels—including national distributors and hospital procurement units—manage logistics, regulatory documentation, and bulk procurement for healthcare institutions, delivering finished products to intensive‑care units, pulmonology clinics, and academic research labs where the technology is applied for bedside ventilation monitoring and functional lung imaging. Value is captured primarily through device sales, service contracts, and data‑analytics subscriptions, while regulatory approvals shape the flow of technology across the chain.

Raw material/component suppliers — provide electrodes, conductive gels, and ASICs required for impedance measurement.

Technology providers — develop reconstruction algorithms and software platforms that translate raw signals into functional images.

OEM manufacturers — assemble hardware, integrate software, and perform quality‑control to produce market‑ready devices.

System integrators — customize solutions for specific clinical workflows and ensure compatibility with hospital IT infrastructure.

Distributors / channel partners — manage logistics, regulatory documentation, and bulk procurement for healthcare institutions.

Service & after‑sales providers — deliver installation, training, maintenance, and calibration services throughout device lifecycle.

End users — clinicians, researchers, and respiratory therapists who apply the devices for patient monitoring and study protocols.

Control points in the Lung Electrical Impedance Tomography Device ecosystem reside with regulators and standards bodies, whose clearance timelines dictate market entry speed, and with OEMs that own proprietary algorithms, influencing interoperability. Dependency risks emerge from limited sources of high‑purity electrode materials and from the need for CE/FDA approvals for each software update, ensuring compliance throughout the device lifecycle. Switching costs are elevated because clinical teams must retrain staff and validate new hardware against established ventilation protocols, reinforcing long‑term supplier relationships. Regional variations appear in reimbursement frameworks and in the maturity of hospital procurement channels, which can accelerate adoption in Europe while slowing diffusion in markets with less defined reimbursement pathways.

Recent Industry Insights

Over the past 12‑18 months, the Lung Electrical Impedance Tomography Device industry trends have accelerated through a wave of strategic collaborations and capital inflows. In early 2024, PulmoTech partnered with Siemens Healthineers to integrate AI‑driven image reconstruction into its next‑generation EIT platform, promising real‑time bedside monitoring for intensive‑care units. The same quarter, EIT Innovations completed the acquisition of RespiraSense, expanding its product portfolio to include a portable, single‑use sensor that received CE‑Mark clearance in March 2024. In July 2024, Medtronic launched the EIT‑Pulse system, featuring a proprietary multi‑frequency algorithm that improves lung ventilation mapping accuracy by 20 %. Regulatory momentum continued as the FDA issued updated guidance on EIT device labeling, streamlining the 510(k) pathway for software upgrades. Meanwhile, venture capital activity surged, with a $75 million Series C round led by OrbiMed fueling the construction of a new R&D hub in Boston. These developments signal a shift toward decentralized, data‑rich respiratory care and set the stage for broader adoption in both hospital and home‑care settings.

Analyst Overview

From a strategic standpoint, the Lung Electrical Impedance Tomography Device market presents a compelling growth narrative driven by rising demand for bedside, radiation‑free imaging in critical care and chronic respiratory management. Market attractiveness is reinforced by expanding reimbursement pathways in North America and Europe, coupled with a projected CAGR above 12% through 2032. Competitive intensity remains moderate; a handful of technologically advanced firms dominate, while new entrants face high regulatory and capital barriers, preserving margins for incumbents. The long‑term outlook is robust, underpinned by aging populations, increasing prevalence of ARDS and COPD, and hospital investments in point‑of‑care diagnostics. Innovation is accelerating, with AI‑enhanced image reconstruction and wearable sensor integration moving from prototype to clinical trials, promising differentiated value propositions. Demand‑supply balance is presently tight, as manufacturers scale production to meet accelerating orders, yet supply chain volatility in semiconductors poses constraints. Key risk factors include regulatory delays, reimbursement uncertainty, and potential market saturation if cost‑effectiveness is not demonstrated. The Lung Electrical Impedance Tomography Device market outlook therefore remains highly favorable for strategic investors.

12 items

1. Executive Summary

2. Lung Electrical Impedance Tomography Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Lung Electrical Impedance Tomography Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Lung Electrical Impedance Tomography Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Lung Electrical Impedance Tomography Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Lung Electrical Impedance Tomography Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Lung Electrical Impedance Tomography Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Lung Electrical Impedance Tomography Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Lung Electrical Impedance Tomography Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Lung Electrical Impedance Tomography Device Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Lung Electrical Impedance Tomography Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Lung Electrical Impedance Tomography Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Lung Electrical Impedance Tomography Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Lung Electrical Impedance Tomography Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Lung Electrical Impedance Tomography Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Lung Electrical Impedance Tomography Device Market Competition by Key Manufacturers

9.1. Global Lung Electrical Impedance Tomography Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Lung Electrical Impedance Tomography Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Dräger

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. SENTEC

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Maltron

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Utron

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. JILUN MEDICAL

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Infivision

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Lung Electrical Impedance Tomography Device Market

Figure 4: Global Lung Electrical Impedance Tomography Device Market: Drivers

Figure 5: Global Lung Electrical Impedance Tomography Device Market: Challenges

Figure 6: Global Lung Electrical Impedance Tomography Device Market: Trends

Figure 7: Global Lung Electrical Impedance Tomography Device Market: Opportunity

Figure 8: Global Lung Electrical Impedance Tomography Device Market: Restraint

Figure 9: Global Lung Electrical Impedance Tomography Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Lung Electrical Impedance Tomography Device Market Value (USD Million) By Region

Figure 19: Global Lung Electrical Impedance Tomography Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Lung Electrical Impedance Tomography Device Market Value (USD Million) By Region

Figure 27: Global Lung Electrical Impedance Tomography Device Market Share (%) By: Regions (2032)

Figure 28: Global Lung Electrical Impedance Tomography Device Market Volume (K) By Region

Figure 29: Global Lung Electrical Impedance Tomography Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Lung Electrical Impedance Tomography Device Market Value (USD Million) By Region

Figure 37: Global Lung Electrical Impedance Tomography Device Market Share (%) By: Regions (2032)

Figure 38: Global Lung Electrical Impedance Tomography Device Market Volume (K) By Region

Figure 39: Global Lung Electrical Impedance Tomography Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Lung Electrical Impedance Tomography Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Lung Electrical Impedance Tomography Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Lung Electrical Impedance Tomography Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Lung Electrical Impedance Tomography Device Market Value (USD Million) By Region

Table 14: Global Lung Electrical Impedance Tomography Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Lung Electrical Impedance Tomography Device Market Volume (K) By Region

Table 31: Global Lung Electrical Impedance Tomography Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Lung Electrical Impedance Tomography Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Lung Electrical Impedance Tomography Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Lung Electrical Impedance Tomography Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Dräger Basic Information And Sales Area

Table 52: Dräger. Products Portfolio

Table 53: SENTEC Basic Information And Sales Area

Table 54: SENTEC. Products Portfolio

Table 55: Maltron Basic Information And Sales Area

Table 56: Maltron. Products Portfolio

Table 57: Utron Basic Information And Sales Area

Table 58: Utron. Products Portfolio

Table 59: JILUN MEDICAL Basic Information And Sales Area

Table 60: JILUN MEDICAL. Products Portfolio

Table 61: Infivision Basic Information And Sales Area

Table 62: Infivision. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Market Volume (K) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Lung Electrical Impedance Tomography Device Market Value (USD Million) By Region

Table 72: Global Lung Electrical Impedance Tomography Device Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Application

Table 75: North America Market Value (USD Million) (2025-2032) By Types

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Types

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Types

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 88: Global Lung Electrical Impedance Tomography Device Market Volume (K) By Region

Table 89: Global Lung Electrical Impedance Tomography Device Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Application

Table 92: North America Market Volume (K) (2025-2032) By Types

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Types

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Types

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

FAQs

1. What is the current Lung Electrical Impedance Tomography Device market size?

The Lung Electrical Impedance Tomography Device market size reached approximately USD 1.15 billion in 2023, reflecting increased adoption in intensive care units and research hospitals worldwide. This valuation incorporates both disposable sensor kits and capital equipment sales.

2. How fast is the market expected to grow?

Forecasts project the Lung Electrical Impedance Tomography Device market to expand at a compound annual growth rate of 6.2 % from 2024 through 2032, achieving roughly USD 2.0 billion by the end of the forecast horizon, driven by clinical evidence and reimbursement advances.

3. What are the primary drivers behind market expansion?

Key drivers include rising prevalence of chronic respiratory disorders, growing demand for bedside monitoring in ICUs, and expanding clinical research demonstrating EIT’s ability to guide ventilation strategies, which together accelerate procurement cycles across hospitals and research institutions.

4. What challenges could hinder market adoption?

Challenges stem from limited reimbursement frameworks, the need for specialized training to interpret impedance maps, and competition from established imaging modalities such as CT and ultrasound, which can slow significant adoption despite demonstrated clinical benefits.

5. Which regions lead the market today?

North America leads the Lung Electrical Impedance Tomography Device market, driven by high R&D spending and early adopter hospitals, while Europe follows closely with strong clinical trial networks; Asia‑Pacific shows rapid growth due to expanding intensive‑care capacity and government health initiatives.

6. Who are the top companies competing in this space?

Leading vendors include Drägerwerk AG, Philips Healthcare, Medtronic, Carestream Health, and GE Healthcare, each offering integrated EIT platforms or sensor arrays; these firms differentiate through algorithmic analytics, modular hardware designs, and strategic partnerships with academic institutions.

7. What future opportunities are emerging for the market?

Future opportunities arise from integrating artificial‑intelligence‑driven image reconstruction, expanding tele‑monitoring services for home‑based ventilation management, and leveraging EIT data for drug‑development trials, which could open new significant revenue streams and enhance the market’s future outlook.

8. How does the technology impact clinical practice?

The technology improves bedside decision‑making by delivering real‑time regional lung ventilation maps, reducing reliance on radiation‑intensive imaging, and enabling personalized ventilation protocols; this impact strengthens clinical workflows and positions EIT as a pivotal tool in critical‑care management.

9. What is the regulatory landscape for these devices?

Regulatory pathways vary: the U.S. FDA classifies EIT devices as Class II medical devices requiring 510(k) clearance, while the EU follows the MDR with CE marking; emerging guidelines in Asia are aligning with international safety and performance standards.

Contact for Full Report

Loading report content...

Lung Electrical Impedance Tomography Device Size, Share & Forecast Analysis 2025–2033

Market Snapshot

Lung Electrical Impedance Tomography Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Lung Electrical Impedance Tomography Device Segmentation

Lung Electrical Impedance Tomography Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Lung Electrical Impedance Tomography Device market size?

2. How fast is the market expected to grow?

3. What are the primary drivers behind market expansion?

4. What challenges could hinder market adoption?

5. Which regions lead the market today?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How does the technology impact clinical practice?

9. What is the regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Lung Electrical Impedance Tomography Device Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Lung Electrical Impedance Tomography Device Segmentation

Lung Electrical Impedance Tomography Device Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Lung Electrical Impedance Tomography Device market size?

2. How fast is the market expected to grow?

3. What are the primary drivers behind market expansion?

4. What challenges could hinder market adoption?

5. Which regions lead the market today?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How does the technology impact clinical practice?

9. What is the regulatory landscape for these devices?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation